skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Mathematical modeling in cancer nanomedicine: a review

Journal Article · · Biomedical Microdevices
 [1];  [1];  [2];  [3];  [1];  [4];  [5];  [5]
  1. The Houston Methodist Research Inst., Houston, TX (United States)
  2. California State Univ. (CalState), Northridge, CA (United States)
  3. Univ. of Naples Federico II (Italy)
  4. Univ. of New Mexico, Albuquerque, NM (United States); Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)
  5. The Houston Methodist Research Inst., Houston, TX (United States); Univ. of Texas, Houston, TX (United States)

Cancer continues to be among the leading healthcare problems worldwide, and efforts continue not just to find better drugs, but also better drug delivery methods. The need for delivering cytotoxic agents selectively to cancerous cells, for improved safety and efficacy, has triggered the application of nanotechnology in medicine. This effort has provided drug delivery systems that can potentially revolutionize cancer treatment. Nanocarriers, due to their capacity for targeted drug delivery, can shift the balance of cytotoxicity from healthy to cancerous cells. The field of cancer nanomedicine has made significant progress, but challenges remain that impede its clinical translation. Several biophysical barriers to the transport of nanocarriers to the tumor exist, and a much deeper understanding of nano-bio interactions is necessary to change the status quo. Mathematical modeling has been instrumental in improving our understanding of the physicochemical and physiological underpinnings of nanomaterial behavior in biological systems. Here, we present a comprehensive review of literature on mathematical modeling works that have been and are being employed towards a better understanding of nano-bio interactions for improved tumor delivery efficacy.

Research Organization:
Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)
Sponsoring Organization:
USDOE National Nuclear Security Administration (NNSA); National Science Foundation (NSF); National Institutes of Health (NIH); University of Texas; USDOE Laboratory Directed Research and Development (LDRD) Program
Grant/Contract Number:
NA0003525; DMS-1716737; 1U01CA196403; 1U01CA213759; 1R01CA226537; 1R01CA222007; U54CA210181
OSTI ID:
1623615
Journal Information:
Biomedical Microdevices, Vol. 21, Issue 2; ISSN 1387-2176
Publisher:
Springer NatureCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 74 works
Citation information provided by
Web of Science

References (138)

Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment: Mifamurtide pharmacokinetics and pharmacodynamics in renal impairment journal May 2014
Towards Optimal Design of Cancer Nanomedicines: Multi-stage Nanoparticles for the Treatment of Solid Tumors journal February 2015
Biomolecular coronas provide the biological identity of nanosized materials journal December 2012
Mechanistic Modeling Identifies Drug-Uptake History as Predictor of Tumor Drug Resistance and Nano-Carrier-Mediated Response journal November 2013
Announcing the worldwide Protein Data Bank journal December 2003
A Computational Model for Predicting Nanoparticle Accumulation in Tumor Vasculature journal February 2013
Computational approaches and metrics required for formulating biologically realistic nanomaterial pharmacokinetic models journal January 2013
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine journal December 2012
Competitive Binding of Proteins to Gold Nanoparticles Disclosed by Molecular Dynamics Simulations journal September 2015
Multiscale Kinetic Modeling of Liposomal Doxorubicin Delivery Quantifies the Role of Tumor and Drug-Specific Parameters in Local Delivery to Tumors journal November 2012
Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner journal April 2017
A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors journal December 2013
Tracking T-cells in vivo with a new nano-sized MRI contrast agent. text January 2012
Preclinical evaluation of genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer. journal May 2013
Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment journal March 2011
A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors journal December 2013
Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia journal November 2000
Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats journal January 2014
Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurements journal August 2013
To scale or not to scale: the principles of dose extrapolation journal July 2009
Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability journal January 2010
Physical Principles of Nanoparticle Cellular Endocytosis journal August 2015
Margination of micro- and nano-particles in blood flow and its effect on drug delivery journal May 2014
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy journal June 2009
The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma journal May 2000
Physiologically Based Pharmacokinetic Modeling of Nanoparticles journal October 2010
A two-step model of TiO 2 nanoparticle toxicity in human liver tissue journal November 2017
Mifamurtide for the treatment of nonmetastatic osteosarcoma journal January 2011
Liposomal Formulations in Clinical Use: An Updated Review journal March 2017
Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer text January 2013
Mathematical modeling in cancer drug discovery journal February 2014
A Theoretical Model for the Margination of Particles within Blood Vessels journal February 2005
Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin journal February 2020
Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes journal June 2017
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner journal April 2012
99m Tc-Labeled Multifunctional Low-Generation Dendrimer-Entrapped Gold Nanoparticles for Targeted SPECT/CT Dual-Mode Imaging of Tumors journal July 2016
Biodistribution and Pharmacokinetic Analysis of Long-Circulating Thiolated Gelatin Nanoparticles Following Systemic Administration in Breast Cancer-Bearing Mice journal February 2007
Understanding and modulating the competitive surface-adsorption of proteins through coarse-grained molecular dynamics simulations journal January 2013
Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics dataset January 2018
Liposomal nanomedicines journal December 2007
Kinetics of the formation of a protein corona around nanoparticles journal December 2016
New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? journal October 2006
Cancer nanomedicine: progress, challenges and opportunities journal November 2016
The Transport of Nanoparticles in Blood Vessels: The Effect of Vessel Permeability and Blood Rheology journal January 2008
Determining the Pharmacokinetics and Long-Term Biodistribution of SiO 2 Nanoparticles In Vivo Using Accelerator Mass Spectrometry journal October 2012
Diffusion Anisotropy in Collagen Gels and Tumors: The Effect of Fiber Network Orientation journal November 2010
The influence of size, shape and vessel geometry on nanoparticle distribution journal July 2012
The effect of interstitial pressure on tumor growth: Coupling with the blood and lymphatic vascular systems journal March 2013
Mechanism of hard-nanomaterial clearance by the liver journal August 2016
Analytical model of magnetic nanoparticle transport and capture in the microvasculature journal June 2006
A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4: PBPK for pregnancy with time-varying physiological parameters journal October 2012
Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer journal July 2013
In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics journal October 2012
Pharmacokinetics of the Urokinase Receptor-Derived Peptide UPARANT After Single and Multiple Doses Administration in Rats journal October 2020
Odyssey of a cancer nanoparticle: From injection site to site of action journal December 2012
Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell Kill journal June 2016
On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better journal June 2013
Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency journal May 2014
Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based Approach journal June 2015
Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies journal June 2004
Effects of particle size and ligand density on the kinetics of receptor-mediated endocytosis of nanoparticles journal January 2010
Dynamic Positron Emission Tomography Imaging of Renal Clearable Gold Nanoparticles journal April 2016
Understanding the Kinetics of Protein–Nanoparticle Corona Formation journal November 2016
Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening journal November 2012
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release journal February 2016
The adhesive strength of non-spherical particles mediated by specific interactions journal October 2006
Tracking T-cells in vivo with a new nano-sized MRI contrast agent. text January 2012
Design of bio-mimetic particles with enhanced vascular interaction journal August 2009
Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics journal October 2018
Understanding Drug Resistance in Breast Cancer with Mathematical Oncology journal April 2014
Dynamics of Nanoparticle-Protein Corona Complex Formation: Analytical Results from Population Balance Equations journal May 2013
Multiscale modelling and nonlinear simulation of vascular tumour growth journal September 2008
Quantitative Whole Body Biodistribution of Fluorescent-Labeled Agents by Non-Invasive Tomographic Imaging journal June 2011
Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats text January 2016
[186Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model journal July 2009
Renal clearance of quantum dots journal September 2007
The Receptor-Mediated Endocytosis of Nonspherical Particles journal May 2008
ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance journal February 2012
Multiscale Cancer Modeling journal August 2011
Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging: Pharmacokinetic Profiling of Nanoparticles With MRI journal November 2008
Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data journal March 2017
Physiologically Based Pharmacokinetic Modeling: Principles and Applications journal October 1983
Influence of red blood cells on nanoparticle targeted delivery in microcirculation journal January 2012
In vivo SPECT/CT imaging and biodistribution using radioactive Cd 125 m Te/ZnS nanoparticles journal April 2007
Understanding the Connection between Nanoparticle Uptake and Cancer Treatment Efficacy using Mathematical Modeling journal May 2018
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia journal November 2006
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies journal January 2003
Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer journal July 2009
The Effective Dispersion of Nanovectors Within the Tumor Microvasculature journal March 2006
Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid journal June 2010
Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages journal January 2011
Evaluation of Drug-Loaded Gold Nanoparticle Cytotoxicity as a Function of Tumor Vasculature-Induced Tissue Heterogeneity journal October 2018
Delivering nanomedicine to solid tumors journal September 2010
Continuous and Discrete Mathematical Models of Tumor-induced Angiogenesis journal September 1998
Predictive Modeling of Drug Response in Non-Hodgkin’s Lymphoma journal June 2015
In Vivo Biodistribution and Clearance Studies Using Multimodal Organically Modified Silica Nanoparticles journal January 2010
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe journal October 2014
Evolution and clinical translation of drug delivery nanomaterials journal August 2017
Nanomedicines for Cancer Therapy: An Update of FDA Approved and Those under Various Stages of Development journal January 2014
Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows journal November 2009
Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: Clinical implications and therapeutic targeting strategies journal August 2006
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems journal August 2012
Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats text January 2016
Biodistribution and Pharmacokinetics of EGFR-Targeted Thiolated Gelatin Nanoparticles Following Systemic Administration in Pancreatic Tumor-Bearing Mice journal April 2013
Coarse-grained model of adsorption of blood plasma proteins onto nanoparticles journal December 2015
Probing In Vivo Trafficking of Polymer/DNA Micellar Nanoparticles Using SPECT/CT Imaging journal September 2011
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development journal August 2013
Tailoring nanoparticle designs to target cancer based on tumor pathophysiology journal February 2016
Dynamic density functional theory of protein adsorption on polymer-coated nanoparticles journal January 2014
Combined mathematical modelling and experimentation to predict polymersome uptake by oral cancer cells journal February 2014
Antitumor Effect of Nanoparticle 131 I-Labeled Arginine-Glycine-Aspartate–Bovine Serum Albumin–Polycaprolactone in Lung Cancer journal May 2017
Impact of Diffusion Barriers to Small Cytotoxic Molecules on the Efficacy of Immunotherapy in Breast Cancer journal April 2013
Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies journal July 2011
Pros and Cons of the Liposome Platform in Cancer Drug Targeting journal January 2006
Tracking T-cells in vivo with a new nano-sized MRI contrast agent journal November 2012
Physiologically Based Pharmacokinetic Modeling: Methodology, Applications, and Limitations with a Focus on Its Role in Pediatric Drug Development journal January 2011
Coarse-grained models for proteins journal April 2005
Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements journal June 2009
Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution journal February 2012
Analysis of nanoparticle delivery to tumours journal April 2016
Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human journal December 2011
Nanomedicines for Cancer Therapy: An Update of FDA Approved and Those under Various Stages of Development journal January 2014
Protein adsorption on nanoparticles: model development using computer simulation journal August 2016
Nonlinear simulation of tumor growth journal March 2003
Simulating cancer growth with multiscale agent-based modeling journal February 2015
A closer look into the ubiquitin corona on gold nanoparticles by computational studies journal January 2015
Dual-radiolabeled nanoparticle SPECT probes for bioimaging journal January 2015
Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions journal January 2016
Machine learning provides predictive analysis into silver nanoparticle protein corona formation from physicochemical properties journal January 2018
Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy journal January 2001
Scale-Invariant Behavior and Vascular Network Formation in Normal and Tumor Tissue journal September 1995
Editorial Special Section on Multiscale Cancer Modeling journal March 2017
Development of a Highly Active Nanoliposomal Irinotecan Using a Novel Intraliposomal Stabilization Strategy journal March 2006
Transport properties of pancreatic cancer describe gemcitabine delivery and response journal March 2014
Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging journal September 2010
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer journal April 2009
A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles journal September 2013
Coarse-grained model of adsorption of blood plasma proteins onto nanoparticles text January 2015

Cited By (5)

Understanding nanoparticle flow with a new in vitro experimental and computational approach using hydrogel channels journal January 2020
Size‐Optimized Ultrasmall Porous Silica Nanoparticles Depict Vasculature‐Based Differential Targeting in Triple Negative Breast Cancer journal September 2019
Nanomaterials for cancer medication: from individual nanoparticles toward nanomachines and nanorobots journal December 2019
Spatio-temporal aspects of the interplay of cancer and the immune system journal November 2019
Improving nanotherapy delivery and action through image-guided systems pharmacology journal January 2020